Cardiac Allograft Vasculopathy clinical trials

Explore recruiting cardiac allograft vasculopathy clinical trials.

Recruiting cardiac allograft vasculopathy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Cardiac Allograft Vasculopathy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

ACAV: EFFICACY AND SAFETY OF ALIROCUMAB TO PREVENT EARLY CARDIAC ALLOGRAFT VASCULOPATHY IN RECENT HEART TRANSPLANT RECIPIENTS

Czechia

Therapeutic use (Phase IV) EU CTIS Study details

Cardiac Allograft Vasculopathy trials by city

Cardiac Allograft Vasculopathy in Toronto Cardiac Allograft Vasculopathy in Vancouver Cardiac Allograft Vasculopathy in Montreal Cardiac Allograft Vasculopathy in Calgary Cardiac Allograft Vasculopathy in Edmonton Cardiac Allograft Vasculopathy in Ottawa Cardiac Allograft Vasculopathy in Winnipeg Cardiac Allograft Vasculopathy in Quebec City Cardiac Allograft Vasculopathy in Hamilton Cardiac Allograft Vasculopathy in Kitchener Cardiac Allograft Vasculopathy in London Cardiac Allograft Vasculopathy in Halifax Cardiac Allograft Vasculopathy in New York Cardiac Allograft Vasculopathy in Los Angeles Cardiac Allograft Vasculopathy in Chicago Cardiac Allograft Vasculopathy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease